BACK TO TOP
KSE100
171,115.82
-1778.45
(-1.03%)
KSE100PR
52,304.80
-552.93
(-1.05%)
ALLSHR
102,630.81
-743.98
(-0.72%)
KSE30
51,478.54
-641.56
(-1.23%)
KMI30
245,731.79
-3035.82
(-1.22%)
BKTI
47,279.59
-660.98
(-1.38%)
OGTI
35,704.94
-598.06
(-1.65%)
KMIALLSHR
66,650.31
-541.20
(-0.81%)
PSXDIV20
79,163.91
-560.90
(-0.70%)
UPP9
60,585.65
-695.66
(-1.14%)
NITPGI
45,586.52
-569.04
(-1.23%)
NBPPGI
49,531.01
-637.85
(-1.27%)
MZNPI
30,235.06
-350.90
(-1.15%)
JSMFI
42,097.48
-354.64
(-0.84%)
ACI
22,609.69
-253.52
(-1.11%)
JSGBKTI
72,548.24
-1005.30
(-1.37%)
HBLTTI
18,330.55
07-05-2026
5.87
(0.03%)
MII30
22,197.30
-240.89
(-1.07%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.80.64
-0.81
(-0.99%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, May 8, 2026 4:49 PM
REG
DFC
CSF
ODL
Open
80.00
High
81.45
Low
79.10
Volume
1,222,698
CIRCUIT BREAKER
73.31 — 89.60
DAY RANGE
79.10 — 81.45
52-WEEK RANGE ^
60.50 — 104.25
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
81.45
VAR
14.00
HAIRCUT
17.50
P/E Ratio (TTM) **
16.77
1-Year Change * ^
20.18%
YTD Change * ^
-4.68%
Last update: Fri, May 8, 2026 4:47 PM
Open
81.00
High
81.98
Low
79.50
Close
81.15
Change
-1.02%
LDCP
81.99
Volume
186,000
Total Trades
156
CIRCUIT BREAKER
73.79 — 90.19
DAY RANGE
79.50 — 81.98
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Apr 26, 2026 8:32 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
84.47
Volume
0
Total Trades
0
CIRCUIT BREAKER
76.02 — 92.92
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Mar 29, 2026 4:05 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
83.23
Volume
0
Total Trades
0
CIRCUIT BREAKER
74.91 — 91.55
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Mar 1, 2026 2:45 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
82.23
Volume
0
Total Trades
0
CIRCUIT BREAKER
74.01 — 90.45
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Muhammad Rasheed AlamCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
18,423,111.17
Shares
228,461,200
Free Float
125,653,660
Free Float
55.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31st March 2026 View   PDF
Apr 30, 2026Financial Results for the Quarter Ended 31 March 2026 View   PDF
Feb 18, 2026Transmission of Quarterly Financial Statements for the Period Ended 2025-12-31 View   PDF
Feb 13, 2026Financial Results for the Quarter Ended December 31, 2025 View   PDF
Oct 30, 2025TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED View   PDF
DateTitleDocument
Apr 23, 2026Board Meeting View   
Feb 3, 2026Board meeting View   
Feb 3, 2026Board Meeting
REVOKED
View   
Nov 13, 2025Certified True Copy of the Resolutions Passed in the Annual General Meeting View   PDF
Oct 29, 2025Board Meeting Other Than Financial Results (Post Election BOD Meeting) View   
DateTitleDocument
May 6, 2026Material Information View   PDF
Apr 27, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Apr 23, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Apr 22, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Mar 30, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,153,52112,409,23912,396,9839,779,880
Profit after Taxation892,039833,464657,984635,884
EPS3.903.652.882.88
Q3 2026Q2 2026Q1 2026Q3 2025
Sales3,084,7464,332,5663,370,2473,341,108
Profit after Taxation275,415404,334203,691220,375
EPS1.211.770.890.96
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)15.3412.7812.1613.83
Net Profit Margin (%)6.786.725.316.50
EPS Growth (%)6.8526.74(20.88)
PEG3.140.29(0.54)

Payouts

Financial Reports